Sorry to hear your position. I was diagnosed in Ovt 2016 had an autologous SCT in April 2017 which failed around Oct 2018. I found it a tougher decision on what to do next. The statistics shows that 2 years to failure is around the average for a myeloma SCT and that a second one on average lasts half as long as the first one. After a number of discussions with my Consultant I decided not to do a second SCT but to take a chemo based treatment. I have been on a Carfilzomib/Dexa combo since Nov 2018 and feeling as good as I did post SCT. The treatment needs regular hospital visits which is a bit of a downside.My treatment has been on hold for the last 3 months due to risk of covid being greater than myeloma risk. I have gave bloods three weeks ago and have a consultation next week Hope for the best.
Andy
